PDF herunterladen
Endoscopy 2005; 37(11): 1131-1135
DOI: 10.1055/s-2005-870409
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Barrett’s Esophagus: a Discrepancy between Macroscopic and Histological Diagnosis

E.  Endlicher1 , P.  Rümmele2 , S.  Beer1 , R.  Knüchel2 , H.  Rath1 , K.  Schlottmann1 , J.  Grossmann1 , U.  Woenckhaus1 , J.  Schölmerich1 , H.  Messmann3
  • 1Dept. of Internal Medicine I, University of Regensburg, Regensburg, Germany
  • 2Institute of Pathology, University of Regensburg, Regensburg, Germany
  • 3Department of Internal Medicine III, Klinikum Augsburg, Augsburg, Germany
Weitere Informationen

Publikationsverlauf

Submitted 13 May 2004

Accepted after revision 15 April 2005

Publikationsdatum:
10. November 2005 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Background and Study Aims: The diagnosis of Barrett’s esophagus at present requires endoscopic and histological confirmation of specialized intestinal metaplasia. This study prospectively analyzed the endoscopic and histological prevalence of Barrett’s esophagus and the risk factors for the presence of Barrett’s esophagus among patients being treated in an endoscopy unit.
Patients and Methods: A total of 474 unselected patients (58 % men; mean age 52 y) were included in the study. Two biopsy specimens each were taken from below and above the squamocolumnar junction and from the antrum and gastric body. Four-quadrant biopsies were taken every 1 - 2 cm to confirm a macroscopic suspicion of Barrett’s esophagus.
Results: Barrett’s esophagus was suspected at endoscopy in 109 patients (23 %). Of the 109 patients with endoscopically suspected Barrett’s esophagus, only 46 (42 %) had the finding confirmed histologically. The sensitivity and specificity for the endoscopic diagnosis of Barrett’s esophagus were 62 % and 84 %, respectively. A multivariate logistic regression analysis identified age (P = 0.0001; odds ratio per life-year 1.087; 95 % CI, 1.046 - 1.139), male sex (P = 0.0020; OR 6.346; 95 % CI, 2.094 - 22.314), and the number of biopsies (P = 0.0025; OR 1.661; 95 % CI, 1.247 - 2.392) as factors associated with evidence of intestinal metaplasia on biopsy.
Conclusion: The striking discrepancy between the endoscopic findings and the histological diagnosis may be due to the focal distribution of intestinal metaplasia. This emphasizes the importance of an adequate biopsy protocol. In addition, better methods of detecting focal islands of intestinal metaplasia that are not visible at conventional endoscopy are needed.

References

  • 1 Cameron A J, Ott B J, Payne W S. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus.  N Engl J Med. 1985;  313 857-859
    CrossrefPubMedSuche in Google Scholar
  • 2 Falk G W. Barrett’s esophagus.  Gastrointest Endosc Clin N Am. 1994;  4 773-789
    PubMedSuche in Google Scholar
  • 3 Palley S L, Sampliner R E, Garewal H S. Management of high-grade dysplasia in Barrett’s esophagus.  J Clin Gastroenterol. 1989;  11 369-372
    PubMedSuche in Google Scholar
  • 4 Spechler S J, Robbins A H, Rubins H B. et al . Adenocarcinoma and Barrett’s esophagus: an overrated risk?.  Gastroenterology. 1984;  87 927-933
    PubMedSuche in Google Scholar
  • 5 Drewitz D J, Sampliner R E, Garewal H S. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years.  Am J Gastroenterol. 1997;  92 212-215
    PubMedSuche in Google Scholar
  • 6 O’Connor J B, Falk G W, Richter J E. The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the Cleveland Clinic Barrett’s Esophagus Registry.  Am J Gastroenterol. 1999;  94 2037-2042
    PubMedSuche in Google Scholar
  • 7 Sampliner R E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology.  Am J Gastroenterol. 2002;  97 1888-1895
    CrossrefPubMedSuche in Google Scholar
  • 8 Hirota W K, Loughney T M, Lazas D J. et al . Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.  Gastroenterology. 1999;  116 277-285
    CrossrefPubMedSuche in Google Scholar
  • 9 Nandurkar S, Talley N J, Martin C J. et al . Short segment Barrett’s oesophagus: prevalence, diagnosis and associations.  Gut. 1997;  40 710-715
    PubMedSuche in Google Scholar
  • 10 Mueller J, Werner M, Stolte M. Barrett’s esophagus: histopathology, definitions and diagnostic criteria.  World J Surg. 2004;  28 148-154
    CrossrefPubMedSuche in Google Scholar
  • 11 Dixon M F, Genta R M, Yardley J H. et al . Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994.  Am J Surg Pathol. 1996;  20 1161-1181
    CrossrefPubMedSuche in Google Scholar
  • 12 Cameron A, Kamath P, Carpenter H. Barrett’s esophagus: the prevalence of short and long segments in reflux patients [abstract].  Gastroenterology. 1995;  91 A65
    PubMedSuche in Google Scholar
  • 13 Weston A P, Krmpotich P, Makdisi W F. et al . Short segment Barrett’s esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia.  Am J Gastroenterol. 1996;  91 981-986
    PubMedSuche in Google Scholar
  • 14 Winters C  Jr, Spurling T J, Chobanian S J. et al . Barrett’s esophagus: a prevalent occult complication of gastroesophageal reflux disease.  Gastroenterology. 1987;  92 118-124
    CrossrefPubMedSuche in Google Scholar
  • 15 Eloubeidi M A, Provenzale D. Does this patient have Barrett’s esophagus? The utility of predicting Barrett’s esophagus at the index endoscopy.  Am J Gastroenterol. 1999;  94 937-943
    CrossrefPubMedSuche in Google Scholar
  • 16 Weinstein W, Leh W, Lewin K. et al . How often is short segment Barrett’s esophagus proven histologically? A prospective study [abstract].  Gastroenterology. 2002;  122 (Suppl) A293
    PubMedSuche in Google Scholar
  • 17 Meining A, Ott R, Becker I. et al . The Munich Barrett follow-up study: suspicion of Barrett’s oesophagus based on either endoscopy or histology only - what is the clinical significance?.  Gut. 2004;  53 1402-1407
    CrossrefPubMedSuche in Google Scholar
  • 18 Ramnath G, Bampton P, Easterman A. A review of current surveillance practice for Barrett’s esophagus: a retrospective analysis of a tertiary hospital endoscopy database [abstract].  Gastrointest Endosc. 2002;  55 AB202
    PubMedSuche in Google Scholar
  • 19 Sharma P, Topalovski M, Mayo M S. et al . Methylene blue chromoendoscopy for detection of short-segment Barrett’s esophagus.  Gastrointest Endosc. 2001;  54 289-293
    CrossrefPubMedSuche in Google Scholar
  • 20 Canto M I, Setrakian S, Willis J. et al . Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus.  Gastrointest Endosc. 2000;  51 560-568
    CrossrefPubMedSuche in Google Scholar
  • 21 Voutilainen M, Farkkila M, Juhola M. et al . Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group.  Am J Gastroenterol. 1999;  94 913-918
    CrossrefPubMedSuche in Google Scholar
  • 22 Spechler S J, Zeroogian J M, Antonioli D A. et al . Prevalence of metaplasia at the gastro-oesophageal junction.  Lancet. 1994;  334 1533-1536
    PubMedSuche in Google Scholar
  • 23 Hackelsberger A, Gunther T, Schultze V. et al . Intestinal metaplasia at the gastroesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?.  Gut. 1998;  43 17-21
    PubMedSuche in Google Scholar
  • 24 Sharma P. Recent advances in Barrett’s esophagus: short-segment Barrett’s esophagus and cardia intestinal metaplasia.  Semin Gastrointest Dis. 1999;  10 93-102
    PubMedSuche in Google Scholar
  • 25 Glickman J N, Shahsafaei A, Odze R D. Mucin core peptide expression can help differentiate Barrett’s esophagus from intestinal metaplasia of the stomach.  Am J Surg Pathol. 2003;  27 1357-1365
    PubMedSuche in Google Scholar
  • 26 Ormsby A H, Vaezi M F, Richter J E. et al . Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett’s esophagus.  Gastroenterology. 2000;  119 683-690
    PubMedSuche in Google Scholar
  • 27 Phillips R W, Frierson H F Jr, Moskaluk C. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.  Am J Surg Pathol. 2003;  27 1442-1447
    PubMedSuche in Google Scholar
  • 28 Weston A P, Krmpotich P T, Cherian R. et al . Prospective long-term endoscopic and histological follow-up of short segment Barrett’s esophagus: comparison with traditional long segment Barrett’s esophagus.  Am J Gastroenterol. 1997;  92 407-413
    PubMedSuche in Google Scholar
  • 29 Chandrasoma P T, Der R, Ma Y. et al . Histology of the gastroesophageal junction: an autopsy study.  Am J Surg Pathol. 2000;  24 402-409
    CrossrefPubMedSuche in Google Scholar

E. Endlicher, M. D.

Dept. of Internal Medicine I, University of Regensburg

93042 Regensburg ·

Fax: +49-941-9447002

eMail: esther.endlicher@klinik.uni-regensburg.de